181 related articles for article (PubMed ID: 7826634)
1. Mutation of an arginine residue in the human glycine receptor transforms beta-alanine and taurine from agonists into competitive antagonists.
Rajendra S; Lynch JW; Pierce KD; French CR; Barry PH; Schofield PR
Neuron; 1995 Jan; 14(1):169-75. PubMed ID: 7826634
[TBL] [Abstract][Full Text] [Related]
2. Hyperekplexia mutations of the glycine receptor unmask the inhibitory subsite for beta-amino-acids.
Laube B; Langosch D; Betz H; Schmieden V
Neuroreport; 1995 Apr; 6(6):897-900. PubMed ID: 7542038
[TBL] [Abstract][Full Text] [Related]
3. Zinc potentiation of the glycine receptor chloride channel is mediated by allosteric pathways.
Lynch JW; Jacques P; Pierce KD; Schofield PR
J Neurochem; 1998 Nov; 71(5):2159-68. PubMed ID: 9798943
[TBL] [Abstract][Full Text] [Related]
4. Murine startle mutant Nmf11 affects the structural stability of the glycine receptor and increases deactivation.
Wilkins ME; Caley A; Gielen MC; Harvey RJ; Smart TG
J Physiol; 2016 Jul; 594(13):3589-607. PubMed ID: 27028707
[TBL] [Abstract][Full Text] [Related]
5. The startle disease mutation Q266H, in the second transmembrane domain of the human glycine receptor, impairs channel gating.
Moorhouse AJ; Jacques P; Barry PH; Schofield PR
Mol Pharmacol; 1999 Feb; 55(2):386-95. PubMed ID: 9927632
[TBL] [Abstract][Full Text] [Related]
6. Characterization of two mutations, M287L and Q266I, in the α1 glycine receptor subunit that modify sensitivity to alcohols.
Borghese CM; Blednov YA; Quan Y; Iyer SV; Xiong W; Mihic SJ; Zhang L; Lovinger DM; Trudell JR; Homanics GE; Harris RA
J Pharmacol Exp Ther; 2012 Feb; 340(2):304-16. PubMed ID: 22037201
[TBL] [Abstract][Full Text] [Related]
7. Startle disease mutations reduce the agonist sensitivity of the human inhibitory glycine receptor.
Rajendra S; Lynch JW; Pierce KD; French CR; Barry PH; Schofield PR
J Biol Chem; 1994 Jul; 269(29):18739-42. PubMed ID: 7518444
[TBL] [Abstract][Full Text] [Related]
8. Differential agonist sensitivity of glycine receptor alpha2 subunit splice variants.
Miller PS; Harvey RJ; Smart TG
Br J Pharmacol; 2004 Sep; 143(1):19-26. PubMed ID: 15302677
[TBL] [Abstract][Full Text] [Related]
9. Comparison of taurine- and glycine-induced conformational changes in the M2-M3 domain of the glycine receptor.
Han NL; Clements JD; Lynch JW
J Biol Chem; 2004 May; 279(19):19559-65. PubMed ID: 14981077
[TBL] [Abstract][Full Text] [Related]
10. Decreased agonist affinity and chloride conductance of mutant glycine receptors associated with human hereditary hyperekplexia.
Langosch D; Laube B; Rundström N; Schmieden V; Bormann J; Betz H
EMBO J; 1994 Sep; 13(18):4223-8. PubMed ID: 7925268
[TBL] [Abstract][Full Text] [Related]
11. Beta-alanine and taurine as endogenous agonists at glycine receptors in rat hippocampus in vitro.
Mori M; Gähwiler BH; Gerber U
J Physiol; 2002 Feb; 539(Pt 1):191-200. PubMed ID: 11850512
[TBL] [Abstract][Full Text] [Related]
12. Disruption of a putative intersubunit electrostatic bond enhances agonist efficacy at the human α1 glycine receptor.
Welsh BT; Todorovic J; Kirson D; Allen HM; Bayly MD; Mihic SJ
Brain Res; 2017 Feb; 1657():148-155. PubMed ID: 27923639
[TBL] [Abstract][Full Text] [Related]
13. The Startle Disease Mutation E103K Impairs Activation of Human Homomeric α1 Glycine Receptors by Disrupting an Intersubunit Salt Bridge across the Agonist Binding Site.
Safar F; Hurdiss E; Erotocritou M; Greiner T; Lape R; Irvine MW; Fang G; Jane D; Yu R; Dämgen MA; Biggin PC; Sivilotti LG
J Biol Chem; 2017 Mar; 292(12):5031-5042. PubMed ID: 28174298
[TBL] [Abstract][Full Text] [Related]
14. A novel hyperekplexia-causing mutation in the pre-transmembrane segment 1 of the human glycine receptor alpha1 subunit reduces membrane expression and impairs gating by agonists.
Castaldo P; Stefanoni P; Miceli F; Coppola G; Del Giudice EM; Bellini G; Pascotto A; Trudell JR; Harrison NL; Annunziato L; Taglialatela M
J Biol Chem; 2004 Jun; 279(24):25598-604. PubMed ID: 15066993
[TBL] [Abstract][Full Text] [Related]
15. A Missense Mutation A384P Associated with Human Hyperekplexia Reveals a Desensitization Site of Glycine Receptors.
Wang CH; Hernandez CC; Wu J; Zhou N; Hsu HY; Shen ML; Wang YC; Macdonald RL; Wu DC
J Neurosci; 2018 Mar; 38(11):2818-2831. PubMed ID: 29440552
[TBL] [Abstract][Full Text] [Related]
16. The unique extracellular disulfide loop of the glycine receptor is a principal ligand binding element.
Rajendra S; Vandenberg RJ; Pierce KD; Cunningham AM; French PW; Barry PH; Schofield PR
EMBO J; 1995 Jul; 14(13):2987-98. PubMed ID: 7621814
[TBL] [Abstract][Full Text] [Related]
17. Mutation of glycine receptor subunit creates beta-alanine receptor responsive to GABA.
Schmieden V; Kuhse J; Betz H
Science; 1993 Oct; 262(5131):256-8. PubMed ID: 8211147
[TBL] [Abstract][Full Text] [Related]
18. The extracellular disulfide loop motif of the inhibitory glycine receptor does not form the agonist binding site.
Vandenberg RJ; Rajendra S; French CR; Barry PH; Schofield PR
Mol Pharmacol; 1993 Jul; 44(1):198-203. PubMed ID: 8393521
[TBL] [Abstract][Full Text] [Related]
19. Kinetic and mutational analysis of Zn2+ modulation of recombinant human inhibitory glycine receptors.
Laube B; Kuhse J; Betz H
J Physiol; 2000 Jan; 522 Pt 2(Pt 2):215-30. PubMed ID: 10639099
[TBL] [Abstract][Full Text] [Related]
20. Ivermectin, an unconventional agonist of the glycine receptor chloride channel.
Shan Q; Haddrill JL; Lynch JW
J Biol Chem; 2001 Apr; 276(16):12556-64. PubMed ID: 11278873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
